
The new drug pain is directed to nerve receptors, without ignoring the addiction pathway
The researchers at the University of Duke have developed a new promising analgesic that works through a completely different mechanism from opioids, which can offer millions of patients with chronic pain an alternative without the dangerous side effects of addiction and tolerance. The experimental medicine, called SBI-810, is directed to specific nerve receptors and spinal…